Valproate robustly enhances AP-1 mediated gene expression

Molecular Brain Research

Volumn 64, Issue 1, 1999, Pages 52-58

  Chen, Guang ^a   Yuan, Pei Xong ^a   Jiang, Yi Ming ^a   Huang, Li Dong ^a   Manji, Husseini K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticonvulsant; AP 1; fos; jun; Mania; Transcription factor; Valproate

Indexed keywords

TRANSCRIPTION FACTOR AP 1; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; TRANSCRIPTION REGULATION;

ANIMALS; ANTICONVULSANTS; BIPOLAR DISORDER; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, REPORTER; GLIOMA; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTATION; NEUROBLASTOMA; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 0033593573     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00303-9     Document Type: Article

References (31)

1. P. Angel, M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, H.J. Rahmsdorf, C. Jonat, P. Herrlich, M. Karin, Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor, Cell 49 (1987) 729-739.
2. V. Asghari, J.F. Wang, J.S. Reiach, L.T. Young, Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells, Molecular Brain Research 58 (1998) 95-102.
3. B.F.D. Bourgeois, in: R. Levy, R. Mattson, B. Meldrum, J.I. Penry, F.F. Dreifuss (Eds.), Valproate: Clinical Use in Antiepileptics, 3rd edn., Raven Press, New York (1989), pp. 633-641.
4. C.L. Bowden, A.M. Brugger, A.C. Swann, J.R. Calabrese, P.G. Janicak, F. Petty, S.C. Dilsaver, J.M. Davis, A.J. Rush, J.G. Small, Efficacy of divalproex vs. lithium and placebo in the treatment of mania, J. Am. Med. Assoc. 271 (1994) 918-924.
5. C.L. Bowden, P.G. Janicak, P. Orsulak, A.C. Swann, J.M. Davis, J.R. Calabrese, P. Goodnick, J.G. Small, A.J. Rush, S.E. Kimmel, S.C. Risch, D.D. Morris, Relation of serum valproate concentration to response in mania, Am. J. Psychiatry 153 (1996) 765-770.
6. W.J. Boyle, T. Smeal, L.H. Defize, P. Angel, J.R. Woodgett, M. Karin, T. Hunter, Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity, Cell 64 (1991) 573-584.
7. J.R. Calabrese, P.J. Markovitz, S.E. Kimmel, S.C. Wagner, Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients, J. Clin. Psychopharmacol. 12 (1) (1992) 53S-56S.
8. G. Chen, H.K. Manji, D.B. Hawver, C.B. Wright, W.Z. Potter, Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro, J. Neurochem. 63 (1994) 2361-2364.
9. G. Chen, P.X. Yuan, D.B. Hawver, W.Z. Potter, H.K. Manji, Increase in AP-1 transcription factor DNA binding activity by valproic acid, Neuropsychopharmacology 16 (1997) 238-245.
10. G. Chen, P.X. Yuan, H.K. Manji, Regulation of Transcription Factor DNA binding activity by mood stabilizing agents, Abstracts of the American College of Neuropsychopharmacology Annual Meeting, Hawaii, December 1997.
11. P. Hughes, M. Dragunow, Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system, Pharmacol. Rev. 47 (1995) 133-178.
12. S.E. Hyman, E.J. Nestler, Initiation and adaptation: a paradigm for understanding psychotropic drug action, Am. J. Psychiatry 153 (1996) 151-162.
13. R.S. Jope, M.B. Williams, Lithium and brain signal transduction systems, Biochem. Pharmacol. 7 (1994) 429-441.
14. M. Karin, T. Smeal, Control of transcription factors by signal transduction pathways: the beginning of the end, TIBS 17 (1992) 418-422.
15. M. Karin, The regulation of AP-1 activity by mitogen-activated protein kinases, J. Biol. Chem. 270 (1995) 16483-16486.
16. G. Kuntz-Simon, G. Obert, Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication, J. Gen. Virol. 76 (1995) 1409-1415.
17. W. Lee, P. Mitchell, R. Tjian, Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements, Cell 49 (1987) 741-752.
18. A. Lin, T. Smeal, B. Binetruy, T. Deng, J.C. Chambard, M. Karin, Control of AP-1 activity by signal transduction cascades, Adv. Second Messenger Phosphoprotein Res. 28 (1993) 255-260.
19. W. Löscher, Effects of the antiepileptic drug valproate on metabolism and function of inhibitory amino acids in the brain, Neurochem. Res. 18 (1993) 484-502.
20. H.K. Manji, W.Z. Potter, R.H. Lenox, Signal transduction pathways: molecular targets for lithium's actions, Arch. Gen. Psychiatry 52 (1995) 531-543.
21. M.L. Martin, C.M. Regan, The anticonvulsant sodium valproate specifically induces the expression of a rat glial heat shock protein which is identified as the collagen type IV receptor, Brain Res. 459 (1988) 131-137.
22. S.L. McElroy, P.E. Keck Jr., H.G. Pope Jr., J.I. Hudson, Valproate in the treatment of bipolar disorder: literature review and clinical guidelines, J. Clin. Psychopharmacol. 12 (1) (1992) 42S-52S.
23. N. Ozaki, D.M. Chuang, Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain, J. Neurochem. 69 (1997) 2336-2344.
24. R.M. Post, S.R. Weiss, D.M. Chuang, Mechanisms of action of anti-convulsants in affective disorders: comparisons with lithium, J. Clin. Psychopharmacol. 12 (1992) 42S-52S.
25. R.M. Post, S.R.B. Weiss, M. Clark, D.M. Chuang, C. Hough, H. Li, Lithium, carbamazepine, and valproate in affective illness: biochemical and neurobiological mechanisms, in: H.K. Manji, C.L. Bowden, R.H. Belmaker (Eds.), Mechanisms of Action of Antibipolar Treatments, American Psychiatric Press, Washington, DC (1998), in press.
26. M.A. Rogawski, R.J. Porter, Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising development stage compounds, Pharmacol. Rev. 42 (1990) 223-286.
27. G. Simon, C. Moog, G. Obert, Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus, Chem. Biol. Interact. 91 (1994) 111-121.
28. V. Stambolic, R. Laurent, J.R. Woodgett, Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells, Current Biology 6 (1996) 1664-1668.
29. J.F. Wang, L.T. Young, P.P. Li, J.J. Warsh, Signal transduction abnormalities in bipolar disorder, in: R.T. Joffe, L.T. Young (Eds.), Bipolar Disorder: Biological Models and their Clinical Application, Marcel Dekker, New York (1997), pp. 41-79.
30. A.J. Whitmarsh, R.J. Davis, Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways, J. Mol. Med. 74 (1996) 589-607.
31. P.X. Yuan, G. Chen, L.D. Huang, H.K. Manji, Lithium stimulates gene expression through the AP-1 transcription factor pathway, Molecular Brain Research 58 (1-2) (1998) 225-230.